[{"会社名":"オンコセラピー・サイエンス(株)【4564】","証券コード":"4564","　":"前期","決算期":"2014年3月期","会計方式":"日本方式","決算発表日":"2014年5月15日","決算月数":"12か月","売上高":"1,017百万円","営業利益":"-3,785百万円","経常利益":"-3,767百万円","当期利益":"-3,676百万円","EPS（一株当たり利益）":"-28.20円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"113.95円","総資産":"18,579百万円","自己資本":"16,723百万円","資本金":"9,082百万円","有利子負債":"---","自己資本比率":"90.0%","ROA（総資産利益率）":"-24.41%","ROE（自己資本利益率）":"-28.16%","総資産経常利益率":"-25.01%"},{"会社名":"オンコセラピー・サイエンス(株)【4564】","証券コード":"4564","　":"2期前","決算期":"2013年3月期","会計方式":"日本方式","決算発表日":"2013年5月15日","決算月数":"12か月","売上高":"3,277百万円","営業利益":"-1,113百万円","経常利益":"-1,113百万円","当期利益":"-1,103百万円","EPS（一株当たり利益）":"-5,113.65円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"43,398.39円","総資産":"11,543百万円","自己資本":"9,387百万円","資本金":"3,573百万円","有利子負債":"---","自己資本比率":"81.3%","ROA（総資産利益率）":"-9.09%","ROE（自己資本利益率）":"-11.11%","総資産経常利益率":"-9.18%"},{"会社名":"オンコセラピー・サイエンス(株)【4564】","証券コード":"4564","　":"3期前","決算期":"2012年3月期","会計方式":"日本方式","決算発表日":"2012年5月14日","決算月数":"12か月","売上高":"6,223百万円","営業利益":"1,184百万円","経常利益":"1,255百万円","当期利益":"726百万円","EPS（一株当たり利益）":"3,476.64円","調整一株当たり利益":"3,097.69円","BPS（一株当たり純資産）":"49,209.08円","総資産":"12,718百万円","自己資本":"10,468百万円","資本金":"3,560百万円","有利子負債":"---","自己資本比率":"82.3%","ROA（総資産利益率）":"6.07%","ROE（自己資本利益率）":"7.19%","総資産経常利益率":"10.50%"}]